Health
Final Results from REPRISE III: Long-Term Stroke Risk after TAVR for Severe Aortic Stenosis – DocWire News
A study presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 Annual Meeting reported the final five-year results…
A study presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 Annual Meeting reported the final five-year results from the REPRISE III randomized trial, which assessed the Lotus Valve transcatheter aortic valve replacement (TAVR) system…
Continue Reading
-
Noosa News22 hours agoPilot left with life-threatening burns to his body as plane crashes to ground in Raglan, Queensland
-
Noosa News16 hours agoTeenage girl killed in house fire in Lawnton, Queensland as police probe potential e-bike link
-
Noosa News24 hours agoWhen will my HECS debt be cut? Millions of Australians wake to 20 per cent cut
-
General23 hours agoHow migrant and overseas Christians are helping keep Australian churches alive